ROP is a blinding disorder that affects prematurely born infants and is a leading cause of blindness, leaving an estimated 20,000 infants blind or severely visually impaired worldwide annually.[2] Current treatments for severe ROP including laser and anti-VEGF agents are helpful in decreasing the risk of blindness. Here, VEGFA is linked to retinopathy of prematurity.